Efficacy, safety and quality-of-life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trial

INTRODUCTION: Trifluridine/tipiracil (FTD/TPI) improved both overall and progression-free survival (OS, PFS) of patients with pre-treated metastatic colorectal cancer (mCRC) in the pivotal phase III RECOURSE trial. However, health-related quality of life (HRQoL) was not assessed directly. To this en...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, L., Karthaus, M., Riera-Knorrenschild, J., Kretzschmar, A., Welslau, M., Vehling-Kaiser, U., Pelz, H., Ettrich, T.J., Hess, J., Reisländer, T., Klein, A., Heinemann, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844683/
https://www.ncbi.nlm.nih.gov/pubmed/35149429
http://dx.doi.org/10.1016/j.esmoop.2022.100391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844683/
https://www.ncbi.nlm.nih.gov/pubmed/35149429
http://dx.doi.org/10.1016/j.esmoop.2022.100391

Ejemplares similares